Navana Pharmaceuticals PLC (DSE: NAVANAPHAR)
Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
50.10
0.00 (0.00%)
At close: Dec 19, 2024

Navana Pharmaceuticals Revenue

Navana Pharmaceuticals had revenue of 2.14B BDT in the quarter ending September 30, 2024, with 31.01% growth. This brings the company's revenue in the last twelve months to 7.40B, up 23.37% year-over-year. In the fiscal year ending June 30, 2024, Navana Pharmaceuticals had annual revenue of 6.90B with 20.89% growth.

Revenue (ttm)
7.40B
Revenue Growth
+23.37%
P/S Ratio
0.73
Revenue / Employee
1.68M
Employees
4,408
Market Cap
5.38B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 20246.90B1.19B20.89%
Jun 30, 20235.71B947.45M19.91%
Jun 30, 20224.76B1.15B31.95%
Jun 30, 20213.61B457.57M14.53%
Jun 30, 20203.15B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition